About the Scientific – The studies were reviewed in this work from a range of sources, such as PubMed, ScienceDirect and a final contribution of chromium effects on glycemic control identified. Total 1,690 people, including 1,505 received chromium picolinate, in these studies. Twelve of the 15 studies were randomized controlled trials and three open-label studies. Picolinate dosages ranged from 200-1000 mcg of chromium per day, and the duration of supplementation ranging from one week to 10 months.

is a greater clinical benefit in diabetes management than other forms of Chromium SupplementsNutrition 21, announced today that a peer-reviewed study was published on chromium picolinate in the current issue of Diabetes Technology & Therapeutics. The analysis confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. The review analyzed the research on chromium picolinate, supports the consistent positive effect of chromium picolinate and refutes a previous review, the efficacy after combining results from all types of supplemental chromium analyzed. .‘courtesy of It can use the total Kaiser Daily Health Policy is reports displayed, search the archives or not sign up for email with an on Kaiser Daily Health policy coverage from press for kaiser network. Releases a free services The Henry J. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.